Evidence of effectiveness for popular herbal medicines

• Autorzy: Pittler M H
• Języki publikacji: EN

Abstrakty

EN

Herbal dietary supplements are among the most popular treatment options, used by about 12 to 34% of respondents. Market analyses indicate that the size of the herbal market in­creased from approximately S 1.6 billion in 1994 to $4 billion in the US in 1998. In 1999, the total US supplement market including vitamins, minerals, herbal and homeopathic remedies was evaluated at $14.5 billion, while the respective figure for Europe is about S 12.3 billion. The objective of this assessment was to evaluate the evidence from systematic reviews and meta-analyses of the effectiveness of popular herbal medicines for selected conditions.

PL

Ziołowe produkty uzupełniające dietę są jednym z najbardziej popularnych specyfików leczniczych. Sięga po nie od 12°ś do 34% badanych. Analizy rynku dowodzą, że w Stanach Zjednoczonych obroty uzyskiwane ze sprzedaży produktów zielarskich wzrosły z 1,6 mld USD w 1994 r. do 4 mld USD w 1998 r. W 1999 r. obroty na całym amerykańskim rynku produktów uzupełniających dietę - włącznie z witaminami, związkami mineralnymi oraz środkami ziołowymi i homeopatycznycmi - oszacowano na 14,5 mld USD. Celem tej pracy jest ocena dowodów podawanych w systematycznie publikowanych przeglądach oraz analiz skuteczności popularnych specyfików ziołowych w wybranych warunkach.

Słowa kluczowe

EN

treatment efficacy; Ginkgo biloba; effectiveness; Crataegus; Echinacea; Allium sativum; Serenoa repens; medicinal herb

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2005
• Tom: 51
• Numer: 1-2
• Opis fizyczny: p.60-65,fig.,ref.

Twórcy

autor

Pittler M H

• University of Exeter and Plymouth, Great Britain

Bibliografia

• 1. Ernst E, Pittler MH, Stevinson C, White A. The Desktop Guide to Complementary and Alternative Medicine. Edinburgh, Mosby 2001.
• 2. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull WHO 2000; 78:252-257.
• 3. Yeh CY, Eisenberg DM, Davis RB et al. Use of complementary and alternative medicine among pei with diabetes mellitus: results of a national survey. Am J Public Health 2002; 92:1648-1652.
• 4. Shmueli A, Shuval J. Use of complementary and alternative medicine in Israel: 2000 vs. 1993. Isr Assoc J 2004; 6:3-8.
• 5. Ernst E, White A. The BBC survey of complementary medicine use in the UK. Comp Ther Med 2000; 8:32-36.
• 6. Thomas KJ, NichollJP, Coleman P. Use and expenditure on complementary medicine in England: a population based survey. Comp Ther Med 2001; 9:2-11.
• 7. Thomas KJ, Coleman P, NichollJP. Trends in access to complementary or alternative medicines via primary care in England: 1995-2001. Results from a follow-up national survey. Family Practice 2003; 20:575-577.
• 8. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004; 343:1-19.
• 9. Brevoort P. The US botanical market. Herbalgram 1996; 36:49-57.
• 10. Brevoort P. The booming US botanical market. Herbalgram 1998; 44:33-48.
• 11. Griinwald J. The supplement markets in the US and Europe. Neutraceuticals World 2000; July/ August:36-37.
• 12. U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, March 1999. Economic Characterization of the Dietary Supplement Industry. Final Report. Available: http:// vm.cfsan.fda.gov/~comm/ds-econt.html (accessed February 27, 2004).
• 13. Blumenthal M. Herb sales down 7.4 percent in mainstream market. Herbalgram 2005; 66:63.
• 14. Birks J, Grimley EvansJ. Ginkgo Biloba for cognitive impairment and dementia. The Cochrane Database of Systematic Reviews 2002, Issue 4.
• 15. Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta­analysis of randomized trials. Am J Med 2000; 108:276-81.
• 16. Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 2000; 133:420-9.
• 17. Ernst E, Stevinson C, Pittler MH. Metaanalyses of garlic for hypercholesterolaemia. In: Schulz Vet al. Phytopharmaka VII. Darmstadt; SteinkopfT2002.
• 18. Melchart D, Linde K, Fischer P, Kaesmayr J. Echinacea for preventing and treating the common cold. The Cochrane Database of Systematic Reviews 1999, Issue 1.
• 19. Wilt T, Ishani A, Mac Donald R. Serenoa repens for benign prostatic hyperplasia. The Cochrane Database of Systematic Reviews 2002, Issue 3.
• 20. Boyle P, Robertson C, Lowe F, Roehrborn C. Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia. Urology 2000; 55:533-9.
• 21. Linde K, Mulrow CD, Berner M, Egger M. St John's Wort for depression. The Cochrane Database of Systematic Reviews 2005, Issue 3. Art.
• 22. Pittler MH, Schmidt K, Ernst E. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 2003; 114:665-74.